{"hands_on_practices": [{"introduction": "B cell development in the bone marrow is a numbers game, governed by the stochastic success of gene rearrangement. The first major hurdle for a pro-B cell is the creation of a functional immunoglobulin heavy chain. This exercise challenges you to apply basic probability theory to this core immunological process, providing a quantitative appreciation for the efficiency of V(D)J recombination and the role of allelic exclusion in maximizing the yield of successful B cell precursors [@problem_id:2883494].", "problem": "In bone marrow pro-B cells, immunoglobulin heavy chain variable-diversity-joining (VDJ) recombination is attempted on two alleles in sequence. A well-established fact is that random joining yields one of three possible reading frames with approximately equal probability, and only an in-frame joining yields a productive heavy chain. Expression of a productive heavy chain forms a pre-B cell receptor (pre-BCR), which triggers allelic exclusion via feedback inhibition of recombination on the other allele. Assume the following foundational facts: (i) each allele’s recombination attempt yields an in-frame productive rearrangement with probability $1/3$, and a nonproductive out-of-frame rearrangement with probability $2/3$; (ii) the outcomes on the two alleles are independent; (iii) recombination on the second allele proceeds only if the first allele’s attempt is nonproductive due to pre-BCR–mediated allelic exclusion. Using only these facts and basic rules of probability, compute the expected fraction of pro-B cells that successfully pass the heavy chain checkpoint (that is, produce at least one productive heavy chain) under this model. Express your final answer as a single simplified exact fraction with no units.", "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded in the principles of immunology, specifically V(D)J recombination and allelic exclusion. The problem is well-posed, with a clear objective and a complete set of non-contradictory assumptions sufficient to derive a unique solution using the fundamental axioms of probability theory. There are no ambiguities, factual errors, or logical inconsistencies.\n\nThe task is to calculate the probability that a pro–B cell successfully produces at least one functional immunoglobulin heavy chain. This process involves sequential attempts at V(D)J recombination on two separate alleles.\n\nLet us define the events for the two alleles, which we will label as allele $1$ and allele $2$.\nLet $S_1$ be the event that the recombination on the first allele is successful (i.e., productive and in-frame).\nLet $F_1$ be the event that the recombination on the first allele fails (i.e., is nonproductive and out-of-frame).\nSimilarly, let $S_2$ and $F_2$ be the corresponding events for the second allele.\n\nAccording to the provided information (i), the probabilities for a single allele are:\n$P(S_1) = \\frac{1}{3}$\n$P(F_1) = \\frac{2}{3}$\n\nThe same intrinsic probabilities apply to the second allele:\n$P(S_2) = \\frac{1}{3}$\n$P(F_2) = \\frac{2}{3}$\n\nThe problem states that recombination on the second allele proceeds only if the first attempt is nonproductive. This is the biological principle of allelic exclusion mediated by the pre-B cell receptor. This introduces a conditional dependency into the sequence of events. A pro–B cell is considered successful if it generates at least one productive rearrangement. This can occur in one of two mutually exclusive scenarios:\n\nScenario $1$: The recombination on the first allele is successful.\nThe probability of this event is $P(S_1)$. If this occurs, recombination on the second allele is inhibited, and the cell has successfully passed the checkpoint.\n$$\nP(\\text{Success in Scenario 1}) = P(S_1) = \\frac{1}{3}\n$$\n\nScenario $2$: The recombination on the first allele fails, but the subsequent recombination on the second allele is successful.\nThis is a compound event. For this scenario to occur, event $F_1$ must happen first, followed by event $S_2$. The probability of this joint event is the probability of the first allele failing, multiplied by the probability of the second allele succeeding *given* that the first one has failed. Since the problem specifies that the attempt on the second allele proceeds *only* if the first fails, and that the outcomes are otherwise independent, we can write:\n$$\nP(\\text{Success in Scenario 2}) = P(F_1 \\cap S_2) = P(F_1) \\times P(S_2 | F_1)\n$$\nThe intrinsic probability of success on the second allele is not altered by the failure of the first, so $P(S_2 | F_1) = P(S_2) = \\frac{1}{3}$. Therefore:\n$$\nP(\\text{Success in Scenario 2}) = P(F_1) \\times P(S_2) = \\frac{2}{3} \\times \\frac{1}{3} = \\frac{2}{9}\n$$\n\nThe total probability of a pro–B cell successfully passing the checkpoint is the sum of the probabilities of these two mutually exclusive scenarios.\n$$\nP(\\text{Total Success}) = P(\\text{Success in Scenario 1}) + P(\\text{Success in Scenario 2})\n$$\n$$\nP(\\text{Total Success}) = P(S_1) + P(F_1 \\cap S_2) = \\frac{1}{3} + \\frac{2}{9}\n$$\nTo sum these fractions, we find a common denominator:\n$$\nP(\\text{Total Success}) = \\frac{3}{9} + \\frac{2}{9} = \\frac{5}{9}\n$$\n\nAlternatively, we can solve this by calculating the probability of the complementary event: total failure. A pro–B cell fails the checkpoint only if recombination fails on *both* alleles. This requires the first allele to fail ($F_1$), and then the second allele to also fail ($F_2$).\n$$\nP(\\text{Total Failure}) = P(F_1 \\cap F_2) = P(F_1) \\times P(F_2 | F_1)\n$$\n$$\nP(\\text{Total Failure}) = \\frac{2}{3} \\times \\frac{2}{3} = \\frac{4}{9}\n$$\nThe probability of success is the complement of the probability of total failure.\n$$\nP(\\text{Total Success}) = 1 - P(\\text{Total Failure}) = 1 - \\frac{4}{9} = \\frac{5}{9}\n$$\nBoth methods yield the same result, which confirms the correctness of the reasoning. The expected fraction of pro–B cells that successfully pass the heavy chain checkpoint is $\\frac{5}{9}$.", "answer": "$$\n\\boxed{\\frac{5}{9}}\n$$", "id": "2883494"}, {"introduction": "The thymus provides a specialized microenvironment that is essential for directing hematopoietic progenitors toward a T cell fate, a decision critically dependent on Notch signaling. This thought experiment requires you to reason from the first principles of developmental biology to predict the outcome of disrupting this master regulatory pathway. By analyzing the consequences of Notch1 deletion, you will learn to view lineage commitment as a dynamic competition between cross-antagonistic gene regulatory networks, a fundamental paradigm in modern immunology [@problem_id:2883493].", "problem": "A cohort of hematopoietic progenitors derived from bone marrow Lymphoid-Primed Multipotent Progenitors (LMPP) is experimentally induced to enter the thymus while lacking functional Notch1 in the hematopoietic compartment, achieved by a conditional deletion that activates upon thymic entry. The cortical thymic epithelial cells (TEC) express Delta-like ligand 4 (Dll4) at normal levels. Early T lineage progenitors (ETP) develop from these LMPP under physiological conditions. Assume cytokines such as Interleukin-7 (IL-7) and Fms-like tyrosine kinase 3 ligand (Flt3L) are present at normal thymic concentrations, and there is no generalized defect in cell survival or migration.\n\nUsing only the following fundamental bases:\n- The Central Dogma (changes in transcription factor activity alter gene expression programs that determine cell fate).\n- Notch-Delta signaling specifies lineage by inducing a target gene program and repressing alternative fates; in the thymus, Dll4-Notch1 interactions are necessary to initiate the T cell gene regulatory network.\n- Lineage commitment emerges from competing, cross-antagonistic gene regulatory networks: the T lineage network (driven by T-cell factor 1 (TCF1; gene Tcf7), GATA-binding protein 3 (GATA3), and B-cell lymphoma/leukemia 11b (Bcl11b), supported by E-proteins E2A/HEB and Notch effectors such as Hairy and enhancer of split-1 (Hes1)); the B lineage network (E2A → Early B-cell Factor 1 (EBF1) → Paired box protein 5 (Pax5) positive feedback); and the myeloid/dendritic network (PU.1 (Spi1), CCAAT/enhancer-binding proteins (C/EBPs), Interferon regulatory factor 8 (IRF8)).\n- Cross-antagonism: activation of the T lineage network represses B and myeloid programs (e.g., by induction of Bcl11b and Gfi1 that constrain PU.1 activity and by Notch-dependent repression of EBF1/Pax5), whereas activation of B (EBF1/Pax5) or myeloid (PU.1/C/EBP) programs represses T lineage genes.\n\nPredict the predominant fate outcomes of these progenitors within the thymus in the absence of Notch1, and select the option that best integrates both the expected phenotypes and the mechanistic explanation in terms of the competing transcriptional networks.\n\nChoose one best answer.\n\n- A. Without Notch1, the T lineage network fails to initiate (loss of TCF1, GATA3, Bcl11b induction), so progenitors default to alternative fates permitted by local cues: ectopic B cells arise via the E2A → EBF1 → Pax5 positive feedback loop, and dendritic/myeloid cells emerge where PU.1/C/EBP remain high; T lineage output collapses because Dll4 cannot signal through Notch.\n\n- B. T lineage development proceeds largely normally because IL-7 can compensate for absent Notch1, while B and myeloid fates remain repressed by residual E-protein activity; any effect is limited to a mild delay at the DN3 pre-T cell receptor checkpoint.\n\n- C. Notch1 loss selectively spares γδ T cells, which expand due to stronger T cell receptor (TCR) signaling, whereas αβ T cells are lost; B and myeloid fates do not increase because early T lineage specification is Notch-independent.\n\n- D. Absence of Notch1 diverts most progenitors into innate lymphoid cell type 2 (ILC2) owing to derepression of Id2 and GATA3, with little to no B cell emergence because EBF1/Pax5 require Notch-dependent priming.", "solution": "We ground the reasoning in gene regulation and signaling. By the Central Dogma, transcription factor networks determine lineage by activating and repressing sets of target genes that stabilize alternative fates. In the thymus, Dll4 on thymic epithelial cells normally engages Notch1 on incoming ETP to initiate the T lineage program. This Notch input is among the earliest lineage-specifying cues in the thymic microenvironment. The well-tested facts are that Notch1 signaling:\n- Induces T lineage transcription factors TCF1 (Tcf7) and GATA3, paving the way for later induction of Bcl11b, which locks in T fate and represses innate and myeloid alternatives.\n- Supports E-protein activity and induces effectors such as Hes1, Gfi1, and Deltex that collectively bias against B lineage (by repressing EBF1/Pax5) and dampen PU.1-driven myeloid programs.\n- Is required prior to divergence of αβ and γδ T cells; both lineages depend on the initial Notch-dependent T specification.\n\nIn a Notch1-deficient hematopoietic compartment, Dll4 cannot trigger Notch transcriptional outputs in the progenitors despite normal ligand on thymic epithelium. Therefore, the T lineage network fails to be initiated: TCF1 and GATA3 are not properly induced, Bcl11b is not activated, and repression of alternative fates is not established. In this context, cross-antagonistic networks compete in the multipotent progenitors. Two outcomes are favored by the thymic milieu and progenitor-intrinsic biases:\n- The B lineage network, fueled by E2A driving EBF1 and then Pax5, can become self-sustaining in the absence of Notch-mediated repression, resulting in ectopic B cell development within the thymus (a phenomenon observed when Notch1 is ablated).\n- The myeloid/dendritic network, under PU.1/C/EBP (with IRF8), can also dominate in some progenitors, particularly with Flt3L support, leading to dendritic cell and myeloid output from the thymus.\n\nBecause the T lineage network is not established, both αβ and γδ T cells are profoundly reduced or absent; there is no early T cell receptor (TCR)-dependent checkpoint engagement without prior T specification. This fate logic follows directly from the competing gene regulatory networks and the loss of Notch1 inputs that normally erect barriers to B and myeloid programs.\n\nOption-by-option analysis:\n- A. This option states that without Notch1, the T lineage network fails to initiate (no TCF1/GATA3/Bcl11b), leading to collapse of T output, while B cells arise via the E2A → EBF1 → Pax5 loop and myeloid/dendritic cells emerge where PU.1/C/EBP remain high. This matches the gene regulatory network logic: removal of Notch-dependent activation and repression removes constraints on B and myeloid networks, allowing them to occupy the attractor states; ectopic thymic B cells and increased dendritic/myeloid output are expected. Verdict — Correct.\n- B. Claims IL-7 compensates for Notch loss and T development is near normal with only a mild delay at DN3. IL-7 supports survival and proliferation but does not replace the lineage-specifying Notch1 signals that induce TCF1/GATA3 and repress B/myeloid programs. Without Notch1, T specification fails far upstream of the DN3 checkpoint. Verdict — Incorrect.\n- C. Proposes selective sparing/expansion of γδ T cells with loss of αβ T cells and no increase in B/myeloid. Although γδ T cells can signal strongly through their TCR, both αβ and γδ lineages require Notch1-dependent T specification at ETP/DN2 stages. In the absence of Notch1, early T lineage entry fails, so neither lineage is preserved, and alternative fates rise. Verdict — Incorrect.\n- D. Suggests diversion predominantly into innate lymphoid cell type 2 (ILC2) based on Id2/GATA3 with little B cell output due to a supposed need for Notch priming of EBF1/Pax5. Notch does not prime EBF1/Pax5; rather, Notch signaling suppresses the B program. Moreover, thymus-derived ILC2 development is typically supported, not opposed, by Notch inputs in many contexts. Without Notch1, a dominant ILC2 outcome is not expected; instead, B and myeloid fates increase. Verdict — Incorrect.", "answer": "$$\\boxed{A}$$", "id": "2883493"}, {"introduction": "The principle of \"one cell, one receptor,\" enforced by allelic exclusion, is a cornerstone of adaptive immunity that ensures clonal specificity. This rule is maintained by tightly regulating the recombination-activating gene (RAG) machinery in response to successful antigen receptor expression. This advanced problem explores the systemic consequences of relaxing this rule, forcing an integrated understanding of how allelic inclusion differently impacts central tolerance in B and T cells and revealing the distinct logic of their respective safety checkpoints [@problem_id:2883471].", "problem": "A research team engineers mice in which recombination-activating gene (RAG) downregulation after successful antigen receptor signaling is uniformly delayed by a controllable interval $\\Delta t$ in both the bone marrow (B cell development) and the thymus (T cell development). In unmanipulated development, allelic exclusion arises because a productive rearrangement on one allele triggers pre-receptor/receptor signaling that extinguishes RAG expression and thereby limits further productive rearrangements on the other allele during the critical window. The team wants to predict how a uniform delay $\\Delta t$ in RAG downregulation will alter allelic inclusion and the risk of autoimmunity in B and T lineages.\n\nUse only the following base facts and definitions to reason your answer:\n- Recombination-activating gene (RAG) endonucleases mediate variable (V), diversity (D), joining (J) recombination. Productive rearrangements on one allele can signal to downregulate RAG, enforcing allelic exclusion.\n- Allelic inclusion denotes stable co-expression of two distinct antigen receptors from both alleles within the same lymphocyte.\n- Central tolerance relies on clonal deletion, anergy, or receptor editing. In B cells, RAG persistence allows light-chain receptor editing that can reduce autoreactivity. In T cells, dual T cell receptor expression can allow positive selection on one receptor while the other receptor escapes negative selection, increasing autoimmunity risk.\n- You may model productive rearrangements while RAG is on as a memoryless process on each allele with rate $\\lambda_{p}$ (per unit time), independent between alleles. Signaling from a productive rearrangement on the first allele occurs sufficiently quickly relative to $\\Delta t$ that the relevant additional opportunity for the second allele to rearrange is the window $\\Delta t$.\n\nFrom these bases, predict how increasing $\\Delta t$ affects:\n(1) the probability that a cell becomes allelically inclusive, and\n(2) the direction of change in autoimmunity risk in B cells and T cells, respectively.\n\nWhich option best matches the expected outcomes and their mechanistic justification?\n\nA. The probability of allelic inclusion increases by approximately $1 - e^{-\\lambda_{p}\\Delta t}$ per cell, and autoimmunity risk increases in T cells due to dual T cell receptor-mediated escape from central tolerance, whereas in B cells the net effect on autoimmunity is ambiguous because enhanced receptor editing (protective) and increased dual B cell receptor expression (risky) act in opposition and the net depends on antigen availability and selection thresholds.\n\nB. The probability of allelic inclusion decreases as $\\Delta t$ increases because persistent RAG activity preferentially promotes nonproductive rearrangements that remove productive receptors, thereby reducing autoimmunity risk in both B and T lineages.\n\nC. The probability of allelic inclusion increases monotonically with $\\Delta t$, and autoimmunity risk uniformly increases in both B and T lineages because more dual receptor cells always escape negative selection.\n\nD. Allelic inclusion is unaffected by $\\Delta t$ because allelic exclusion is enforced post-transcriptionally downstream of RAG, and autoimmunity risk is therefore unchanged in both lineages.", "solution": "The problem as stated is subjected to validation.\n\n**Step 1: Extraction of Givens**\n-   A system of engineered mice is established where recombination-activating gene (RAG) downregulation is delayed by a controllable interval $\\Delta t$ following a successful antigen receptor signaling event. This delay is uniform for B cell development in bone marrow and T cell development in the thymus.\n-   The standard mechanism of allelic exclusion involves a productive rearrangement on one allele signaling to suppress RAG expression, thereby preventing rearrangement on the second allele.\n-   **Definition of RAG**: RAG endonucleases perform Variable (V), Diversity (D), and Joining (J) recombination.\n-   **Definition of Allelic Inclusion**: The stable co-expression of two distinct antigen receptors produced from both alleles within a single lymphocyte.\n-   **Central Tolerance Mechanisms**: Clonal deletion, anergy, or receptor editing.\n-   **B Cell Specifics**: RAG persistence enables light-chain receptor editing, which can mitigate autoreactivity.\n-   **T Cell Specifics**: Dual T cell receptor (TCR) expression can lead to autoimmunity. A cell may undergo positive selection via one TCR, while a second, autoreactive TCR escapes negative selection.\n-   **Modeling Assumption**: Productive rearrangements are modeled as a memoryless process (Poisson process) occurring with a rate $\\lambda_{p}$ on each allele. The processes on the two alleles are independent. The signaling after the first productive rearrangement is assumed to be instantaneous relative to $\\Delta t$, making the additional window for the second allele's rearrangement precisely $\\Delta t$.\n\n**Step 2: Validation of Problem Statement**\n-   **Scientific Grounding**: The problem is constructed upon established principles of immunology, including V(D)J recombination, the function of RAG enzymes, the mechanism of allelic exclusion, and the distinct pathways of central tolerance for B and T lymphocytes. The experimental model described is a valid and commonly used conceptual framework in immunological research. The premises are factually sound.\n-   **Well-Posedness**: The problem is well-posed. It specifies a parameter, $\\Delta t$, and asks for its effect on well-defined outcomes (probability of allelic inclusion, risk of autoimmunity). The provided model, based on a Poisson process, is sufficient to deduce a qualitative and even a quantitative relationship for the probability aspect.\n-   **Objectivity**: The language is technical, precise, and devoid of subjective claims. All terms are defined within the context of the problem or are standard in the field.\n\n**Step 3: Verdict**\nThe problem statement is scientifically sound, self-contained, and well-posed. It contains no logical contradictions or factual errors. Therefore, it is deemed **valid**. We proceed to the solution.\n\n**Derivation of Solution**\n\nThe problem requires a two-part analysis: first, the effect of $\\Delta t$ on the probability of allelic inclusion, and second, the consequent effect on autoimmunity risk in B and T cells.\n\n**Part 1: Probability of Allelic Inclusion**\nThe problem defines a scenario where, after a productive rearrangement on one allele, RAG activity persists for an additional time interval $\\Delta t$. During this interval, the second allele has an opportunity to undergo a productive rearrangement.\n\nThe process of productive rearrangement is modeled as a memoryless process with a constant rate $\\lambda_{p}$. This corresponds to a Poisson process. The waiting time for the next event in a Poisson process follows an exponential distribution.\n\nLet $T$ be the random variable representing the time until a productive rearrangement occurs on the second allele, given that RAG is active. The probability density function of $T$ is $f(t) = \\lambda_{p}e^{-\\lambda_{p}t}$ for $t \\ge 0$.\n\nAllelic inclusion will occur if a productive rearrangement happens on the second allele within the time window $\\Delta t$. The probability of this event, which we can denote $P_{inc}$, is the probability that $T \\le \\Delta t$.\n\nThis probability is calculated by integrating the probability density function from $0$ to $\\Delta t$:\n$$P_{inc} = P(T \\le \\Delta t) = \\int_{0}^{\\Delta t} \\lambda_{p}e^{-\\lambda_{p}t} dt$$\nEvaluating the integral:\n$$P_{inc} = \\left[ -e^{-\\lambda_{p}t} \\right]_{0}^{\\Delta t} = (-e^{-\\lambda_{p}\\Delta t}) - (-e^{-\\lambda_{p} \\cdot 0}) = 1 - e^{-\\lambda_{p}\\Delta t}$$\nThis expression, $1 - e^{-\\lambda_{p}\\Delta t}$, represents the conditional probability that a lymphocyte becomes allelically inclusive, given that it has already undergone one successful rearrangement and RAG activity is prolonged by $\\Delta t$.\n\nAs $\\Delta t$ increases from $0$, the term $e^{-\\lambda_{p}\\Delta t}$ decreases from $1$ towards $0$. Consequently, the probability of allelic inclusion, $P_{inc}$, increases monotonically with $\\Delta t$.\n\n**Part 2: Autoimmunity Risk**\n\nWe must analyze the consequences of increased allelic inclusion in T cells and B cells separately, based on the provided facts.\n\n**T Cells:**\nThe problem states: \"In T cells, dual T cell receptor expression can allow positive selection on one receptor while the other receptor escapes negative selection, increasing autoimmunity risk.\"\nThis provides a direct causal link. An increase in $\\Delta t$ leads to an increase in the probability of allelic inclusion, resulting in more dual-TCR T cells. The presence of two different TCRs compromises the central tolerance mechanism of negative selection. A potentially autoreactive TCR can be carried by a cell that survives because its other TCR passed positive selection and did not trigger a strong negative selection signal. Thus, an increase in $\\Delta t$ directly leads to an increased risk of T-cell-mediated autoimmunity.\n\n**B Cells:**\nThe situation in B cells is more complex. The problem highlights two competing effects of persistent RAG activity:\n1.  **Protective Effect (Receptor Editing)**: \"In B cells, RAG persistence allows light-chain receptor editing that can reduce autoreactivity.\" If a newly formed B cell receptor (BCR) is autoreactive, sustained RAG activity allows the cell to replace the autoreactive light chain with a new one. An increased $\\Delta t$ enhances the time window for this protective mechanism.\n2.  **Harmful Effect (Allelic Inclusion)**: An increase in $\\Delta t$ also increases the generation of dual-BCR B cells. If a cell expresses one non-autoreactive BCR and one autoreactive BCR, the non-autoreactive receptor may allow the cell to survive tolerance checkpoints that it would otherwise have failed, thereby increasing the number of potentially autoreactive cells in the periphery.\n\nThe net effect on autoimmunity risk in the B cell lineage is the sum of these two opposing consequences. Enhanced receptor editing reduces autoimmunity, while increased generation of dual-receptor cells increases it. The problem does not provide sufficient information to determine which effect dominates. The outcome would depend on parameters not given, such as the intrinsic frequency of generating autoreactive receptors, the relative efficiencies of receptor editing versus clonal deletion, and the stringency of peripheral tolerance checkpoints. Therefore, the net effect on B-cell-mediated autoimmunity is ambiguous.\n\n**Summary of Predictions:**\n-   The probability of allelic inclusion increases with $\\Delta t$, following the function $1 - e^{-\\lambda_{p}\\Delta t}$.\n-   The risk of autoimmunity in T cells increases.\n-   The net change in autoimmunity risk in B cells is ambiguous due to the opposing effects of enhanced receptor editing and increased dual-receptor expression.\n\n**Evaluation of Options**\n\n**A. The probability of allelic inclusion increases by approximately $1 - e^{-\\lambda_{p}\\Delta t}$ per cell, and autoimmunity risk increases in T cells due to dual T cell receptor-mediated escape from central tolerance, whereas in B cells the net effect on autoimmunity is ambiguous because enhanced receptor editing (protective) and increased dual B cell receptor expression (risky) act in opposition and the net depends on antigen availability and selection thresholds.**\n-   The probability calculation is correct as derived above.\n-   The analysis of autoimmunity risk in T cells is correct and consistent with the provided premises.\n-   The analysis of autoimmunity risk in B cells correctly identifies the competing mechanisms and the resulting ambiguity.\n-   **Verdict: Correct.**\n\n**B. The probability of allelic inclusion decreases as $\\Delta t$ increases because persistent RAG activity preferentially promotes nonproductive rearrangements that remove productive receptors, thereby reducing autoimmunity risk in both B and T lineages.**\n-   This claim that inclusion probability decreases is directly contrary to our derivation and the logic of the system. A longer window for rearrangement can only increase, not decrease, the probability of a second event.\n-   The proposed mechanism is flawed. RAG acts on unrearranged gene segments; it does not \"remove\" productive receptors.\n-   **Verdict: Incorrect.**\n\n**C. The probability of allelic inclusion increases monotonically with $\\Delta t$, and autoimmunity risk uniformly increases in both B and T lineages because more dual receptor cells always escape negative selection.**\n-   The statement that inclusion probability increases monotonically is correct.\n-   However, the claim that autoimmunity risk \"uniformly increases in both B and T lineages\" is incorrect. It ignores the explicit information given in the problem statement about the protective role of receptor editing in B cells. This option oversimplifies the B cell biology presented.\n-   **Verdict: Incorrect.**\n\n**D. Allelic inclusion is unaffected by $\\Delta t$ because allelic exclusion is enforced post-transcriptionally downstream of RAG, and autoimmunity risk is therefore unchanged in both lineages.**\n-   This contradicts the central premise of the problem, which states that RAG downregulation is a key part of the allelic exclusion mechanism. If RAG downregulation is delayed, allelic exclusion must be affected.\n-   The assertion that exclusion is \"enforced post-transcriptionally downstream of RAG\" is an external claim that invalidates the problem's own stated mechanism. We must reason from the givens.\n-   **Verdict: Incorrect.**\n\nBased on rigorous derivation from the provided statements, Option A is the only one that correctly synthesizes all parts of the problem.", "answer": "$$\\boxed{A}$$", "id": "2883471"}]}